A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 14 Dec 2016
At a glance
- Drugs Paclitaxel poliglumex (Primary) ; Carboplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 21 Oct 2008 Status changed from recruiting to discontinued.
- 16 Jul 2008 New trial record.